Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program.
暂无分享,去创建一个
S. Fowler | S. Haffner | T. Orchard | M. Temprosa | R. Ratner | R. Goldberg | S. Marcovina
[1] S. Haffner,et al. Hypertension, Insulin, and Proinsulin in Participants With Impaired Glucose Tolerance , 2002, Hypertension.
[2] J. Shaw,et al. Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention , 2002, Diabetic medicine : a journal of the British Diabetic Association.
[3] S. Fowler,et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. , 2002 .
[4] W. Dietz,et al. Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. , 2002, JAMA.
[5] The Diabetes Prevention Program (DPP): description of lifestyle intervention. , 2002, Diabetes care.
[6] C. Loria,et al. Subclinical states of glucose intolerance and risk of death in the U.S. , 2001, Diabetes care.
[7] S. Kahn,et al. Abnormal glucose tolerance and increased risk for cardiovascular disease in Japanese-Americans with normal fasting glucose. , 2001, Diabetes care.
[8] E. Feskens,et al. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. , 2001, Archives of internal medicine.
[9] S. Yusuf,et al. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators. , 2000 .
[10] C. Champagne,et al. The Diabetes Prevention Program: baseline characteristics of the randomized cohort. The Diabetes Prevention Program Research Group. , 2000, Diabetes care.
[11] Ames,et al. Gemfibrozil for the secondary prevention of coronary heart disease in men with low levels of high-density lipoprotein cholesterol. Veterans Affairs High-Density Lipoprotein Cholesterol Intervention Trial Study Group. , 1999, The New England journal of medicine.
[12] S. Haffner,et al. Reduced coronary events in simvastatin-treated patients with coronary heart disease and diabetes or impaired fasting glucose levels: subgroup analyses in the Scandinavian Simvastatin Survival Study. , 1999, Archives of internal medicine.
[13] S. Yusuf,et al. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. , 1999, Diabetes care.
[14] Melvin Prince,et al. The Diabetes Prevention Program. Design and methods for a clinical trial in the prevention of type 2 diabetes. , 1999, Diabetes care.
[15] B. Davis,et al. Cardiovascular events and their reduction with pravastatin in diabetic and glucose-intolerant myocardial infarction survivors with average cholesterol levels: subgroup analyses in the cholesterol and recurrent events (CARE) trial. The Care Investigators. , 1998, Circulation.
[16] J. Croft,et al. Impaired glucose tolerance and the likelihood of nonfatal stroke and myocardial infarction: the Third National Health and Nutrition Examination Survey. , 1998, Stroke.
[17] M. Laakso,et al. Epidemiology of risk factors for cardiovascular disease in diabetes and impaired glucose tolerance. , 1997, Atherosclerosis.
[18] R N Bergman,et al. Low insulin sensitivity is associated with clustering of cardiovascular disease risk factors. , 1997, American journal of epidemiology.
[19] H. Gerstein. Glucose: a Continuous Risk Factor for Cardiovascular Disease , 1997, Diabetic medicine : a journal of the British Diabetic Association.
[20] P J Hannan,et al. Prognostic associations of Minnesota Code serial electrocardiographic change classification with coronary heart disease mortality in the Multiple Risk Factor Intervention Trial. , 1997, The American journal of cardiology.
[21] R. Bain,et al. Predictors of Progression From Impaired Glucose Tolerance to NIDDM: An Analysis of Six Prospective Studies , 1997, Diabetes.
[22] K. Yano,et al. Impaired Glucose Tolerance, Diabetes, and Cardiovascular Disease Risk Factor Profiles in the Elderly: The Honolulu Heart Program , 1996, Diabetes Care.
[23] R. Bergman,et al. Insulin Sensitivity and Atherosclerosis , 1996 .
[24] M. Stern. Diabetes and Cardiovascular Disease: The “Common Soil” Hypothesis , 1995, Diabetes.
[25] P. Diggle. Analysis of Longitudinal Data , 1995 .
[26] J. Mckenney,et al. Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II) , 1993, JAMA.
[27] C. Jackson,et al. A comparison of the relationships of the glucose tolerance test and the glycated haemoglobin assay with diabetic vascular disease in the community. The Islington Diabetes Survey. , 1992, Diabetes research and clinical practice.
[28] P. Wilson,et al. Is hyperglycemia associated with cardiovascular disease? The Framingham Study. , 1991, American heart journal.
[29] D. Reed,et al. Postchallenge Glucose Concentration and Coronary Heart Disease in Men of Japanese Ancestry: Honolulu Heart Program , 1987, Diabetes.
[30] L. Wilhelmsen,et al. Fasting Blood Glucose and Risk of Coronary Heart Disease, Stroke, and All‐cause Mortality: A 17‐year Follow‐up Study of Men Born in 1913 , 1986, Diabetic medicine : a journal of the British Diabetic Association.
[31] Warnick Gr. Enzymatic methods for quantification of lipoprotein lipids. , 1986 .
[32] G. Warnick. Enzymatic methods for quantification of lipoprotein lipids. , 1986, Methods in enzymology.
[33] A. Marty. Minnesota Code Manual of Electrocardiographic Findings , 1983 .
[34] J. Albers,et al. Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. , 1982, Clinical chemistry.
[35] M. Shipley,et al. CORONARY-HEART-DISEASE RISK AND IMPAIRED GLUCOSE TOLERANCE The Whitehall Study , 1980, The Lancet.
[36] T. Welborn,et al. Coronary Heart Disease Incidence and Cardiovascular Mortality in Busselton with Reference to Glucose and Insulin Concentrations , 1979, Diabetes Care.
[37] S. Punsar,et al. Glucose tolerance and coronary heart disease: Helsinki policemen study. , 1979, Journal of chronic diseases.
[38] R. Levy,et al. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. , 1972, Clinical chemistry.